Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
royalty payments
Pharma
Syndax strikes $350M funding deal with Royalty Pharma
To help foot the bill for two commercial launches, Syndax Pharmaceuticals has struck a $350 million deal with Royalty Pharma.
Kevin Dunleavy
Nov 5, 2024 10:50am
Ferring cuts ribbon at new gene therapy manufacturing hub
Oct 3, 2024 12:07pm
Penn sues BioNTech over Comirnaty royalties
Aug 7, 2024 7:30am
BioNTech hit with 'notice of default' in COVID royalty dispute
Mar 25, 2024 9:35am
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
Theravance, Ultragenyx sell royalties for $1.8B
Jul 14, 2022 11:48am
